# Study of Belatacept in Subjects Who Are Undergoing a Renal Transplant

> **NCT00114777** · PHASE3 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 595 (actual)

## Conditions studied

- Renal Transplantation

## Interventions

- **DRUG:** Cyclosporin A
- **DRUG:** Belatacept Less Intensive Regimen (LI)
- **DRUG:** Belatacept More Intensive Regimen (MI)

## Key facts

- **NCT ID:** NCT00114777
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2008-05
- **Final completion:** 2014-09
- **Target enrollment:** 595 (ACTUAL)
- **Last updated:** 2017-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00114777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00114777, "Study of Belatacept in Subjects Who Are Undergoing a Renal Transplant". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00114777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*